Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Mark Plander

1PUBLICATIONS
0CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

Sort by Publication Date:
|Oct 26, 2018
Standard Dose of Ibrutinib is Effective in the Treatment of Bing-Neel Syndrome.

Mark Plander, Tamás Szendrei, Árpád Vadvári

Pageof 1

Frequent Collaborators

Frequent Collaborators

Top Related Videos

Intermittent Binge-Intake Model in Mice
05:15

Intermittent Binge-Intake Model in Mice

Published on : Jan 10, 2025

1.7K
See more related videos

Top Related Videos

Intermittent Binge-Intake Model in Mice
05:15

Intermittent Binge-Intake Model in Mice

Published on : Jan 10, 2025

1.7K
See more related videos